BindingDB logo
myBDB logout

null

SMILES: O=C(Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1)NCc1ccc(cc1)C#N

InChI Key:

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 493099   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Tyrosine-protein kinase JAK1 [574-1154]


(Homo sapiens (Human))
BDBM493099
PNG
(N-(4-Cyanobenzyl)-2-(1-((1r,4r)-4-(cyanomethyl)cyc...)
Show SMILES O=C(Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1)NCc1ccc(cc1)C#N |r,wU:18.21,wD:15.17,(-3.18,-2.29,;-2.41,-.96,;-.87,-.96,;-.1,-2.29,;-.72,-3.7,;.42,-4.73,;.42,-6.27,;1.75,-7.04,;3.09,-6.27,;4.55,-6.75,;5.46,-5.5,;4.55,-4.26,;3.09,-4.73,;1.75,-3.96,;1.43,-2.46,;2.46,-1.31,;3.97,-1.63,;5,-.49,;4.52,.98,;5.56,2.12,;7.06,1.8,;8.57,1.48,;3.02,1.3,;1.99,.15,;-3.18,.37,;-4.72,.37,;-5.49,1.71,;-4.72,3.04,;-5.49,4.37,;-7.03,4.37,;-7.8,3.04,;-7.03,1.71,;-7.8,5.71,;-8.57,7.04,)|
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.200n/an/an/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
11-point dosing series were made for each compound by serially diluting 1:3 or 1:4 in DMSO, with point 12 being a DMSO control. From the serial dilut...


US Patent US10981911 (2021)

More data for this
Ligand-Target Pair
Non-receptor tyrosine-protein kinase TYK2 [580-1182,C936A,C1142A]


(Homo sapiens (Human))
BDBM493099
PNG
(N-(4-Cyanobenzyl)-2-(1-((1r,4r)-4-(cyanomethyl)cyc...)
Show SMILES O=C(Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1)NCc1ccc(cc1)C#N |r,wU:18.21,wD:15.17,(-3.18,-2.29,;-2.41,-.96,;-.87,-.96,;-.1,-2.29,;-.72,-3.7,;.42,-4.73,;.42,-6.27,;1.75,-7.04,;3.09,-6.27,;4.55,-6.75,;5.46,-5.5,;4.55,-4.26,;3.09,-4.73,;1.75,-3.96,;1.43,-2.46,;2.46,-1.31,;3.97,-1.63,;5,-.49,;4.52,.98,;5.56,2.12,;7.06,1.8,;8.57,1.48,;3.02,1.3,;1.99,.15,;-3.18,.37,;-4.72,.37,;-5.49,1.71,;-4.72,3.04,;-5.49,4.37,;-7.03,4.37,;-7.8,3.04,;-7.03,1.71,;-7.8,5.71,;-8.57,7.04,)|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 10n/an/an/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
11-point dosing series were made for each compound by serially diluting 1:3 or 1:4 in DMSO, with point 12 being a DMSO control. From the serial dilut...


US Patent US10981911 (2021)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK3 [512-1124]


(Homo sapiens (Human))
BDBM493099
PNG
(N-(4-Cyanobenzyl)-2-(1-((1r,4r)-4-(cyanomethyl)cyc...)
Show SMILES O=C(Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1)NCc1ccc(cc1)C#N |r,wU:18.21,wD:15.17,(-3.18,-2.29,;-2.41,-.96,;-.87,-.96,;-.1,-2.29,;-.72,-3.7,;.42,-4.73,;.42,-6.27,;1.75,-7.04,;3.09,-6.27,;4.55,-6.75,;5.46,-5.5,;4.55,-4.26,;3.09,-4.73,;1.75,-3.96,;1.43,-2.46,;2.46,-1.31,;3.97,-1.63,;5,-.49,;4.52,.98,;5.56,2.12,;7.06,1.8,;8.57,1.48,;3.02,1.3,;1.99,.15,;-3.18,.37,;-4.72,.37,;-5.49,1.71,;-4.72,3.04,;-5.49,4.37,;-7.03,4.37,;-7.8,3.04,;-7.03,1.71,;-7.8,5.71,;-8.57,7.04,)|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 142n/an/an/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
11-point dosing series were made for each compound by serially diluting 1:3 or 1:4 in DMSO, with point 12 being a DMSO control. From the serial dilut...


US Patent US10981911 (2021)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2 [532-1132]


(Homo sapiens (Human))
BDBM493099
PNG
(N-(4-Cyanobenzyl)-2-(1-((1r,4r)-4-(cyanomethyl)cyc...)
Show SMILES O=C(Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1)NCc1ccc(cc1)C#N |r,wU:18.21,wD:15.17,(-3.18,-2.29,;-2.41,-.96,;-.87,-.96,;-.1,-2.29,;-.72,-3.7,;.42,-4.73,;.42,-6.27,;1.75,-7.04,;3.09,-6.27,;4.55,-6.75,;5.46,-5.5,;4.55,-4.26,;3.09,-4.73,;1.75,-3.96,;1.43,-2.46,;2.46,-1.31,;3.97,-1.63,;5,-.49,;4.52,.98,;5.56,2.12,;7.06,1.8,;8.57,1.48,;3.02,1.3,;1.99,.15,;-3.18,.37,;-4.72,.37,;-5.49,1.71,;-4.72,3.04,;-5.49,4.37,;-7.03,4.37,;-7.8,3.04,;-7.03,1.71,;-7.8,5.71,;-8.57,7.04,)|
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.30n/an/an/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
11-point dosing series were made for each compound by serially diluting 1:3 or 1:4 in DMSO, with point 12 being a DMSO control. From the serial dilut...


US Patent US10981911 (2021)

More data for this
Ligand-Target Pair